<DOC>
	<DOCNO>NCT00231348</DOCNO>
	<brief_summary>The purpose study determine effectiveness nefazadone patient social anxiety disorder ( SAD ) .</brief_summary>
	<brief_title>Nefazodone Treatment Social Phobia</brief_title>
	<detailed_description>The purpose study examine efficacy 5HT2 receptor antagonist nefazadone SAD , explore regional cerebral blood flow patient SAD confront personal phobic stimulus , use positron emission tomography ( PET ) . Changes cerebral blood flow correlate self-rated anxiety measure .</detailed_description>
	<mesh_term>Anxiety Disorders</mesh_term>
	<mesh_term>Phobic Disorders</mesh_term>
	<mesh_term>Nefazodone</mesh_term>
	<criteria>DSMIV diagnosis generalize social anxiety disorder , male female age 1865 A history bipolar disorder , psychotic illness , anxiety disorder , organic brain disease active drug alcohol abuse within one year assess SCIDP interview , concurrent medical condition would compatible study opinion principal investigator . Patients require free psychotropic betablocker medication 2 week prior study . Pts take fluoxetine require drugfree 6 week .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>November 2013</verification_date>
	<keyword>Social anxiety disorder</keyword>
	<keyword>social phobia</keyword>
	<keyword>positron emission tomography ( PET</keyword>
	<keyword>regional cerebral blood flow ( rCBF )</keyword>
	<keyword>nefazodone</keyword>
	<keyword>amygdala</keyword>
</DOC>